Long Position on IART @ $58.00 on 4/26/2018 (Momentum)

Integra LifeSciences Holdings Corporation (IART) develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery.

The company operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies.

It offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment.

The company also sells approximately 60,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, it provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair.

Further, the company sells hardware products, such as bone and joint fixation, and joint replacement devices; implants; and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures.

Integra LifeSciences Holdings Corporation offers its products directly through various sales forces and other distribution channels in the United States, Europe, and internationally.

Yesterday, shares broke out of their bullish "cup and handle" on strong earnings. We expect shsres to see a modest pullback, which should be used as an entry point. 

Entry Point: $58.00

Stop Loss: $55.10

52-Weeks Trading Range: $41.51 - $59.30

Target Price: $63.80

Position closed on 5/8/2018 at price of $64.65 with a 11.47% gain in 12 days.

Back to Portfolio